Advanced Cyclic Peptide Synthesis in Drug Discovery

Cyclic Peptide Synthesis: Overcoming Challenges in Drug Discovery

Natural cyclic peptides have become increasingly important in drug discovery due to their distinctive structural frameworks and potent biological activities. More than forty cyclic peptides and their derivatives have already received clinical approval, with applications spanning antibiotics, anticancer agents, immunomodulators, and anti-inflammatory drugs. However, their limited natural abundance, structural complexity, and multiple chiral centers create significant hurdles for efficient synthesis and scalable production. Recent literature, including a comprehensive review by Buchanan et al. (2025) in Biomedicines, sheds light on the synthetic challenges and emerging strategies that are shaping this field.

The Therapeutic Value of Cyclic Peptides and Their Synthetic Hurdles

The constrained conformational state of cyclic peptides underlies their therapeutic advantages over linear peptides. Cyclization confers enhanced metabolic stability through protection from protease degradation, improved target binding affinity via reduced conformational entropy, increased bioavailability due to better membrane permeability, and higher target specificity resulting from a rigid three-dimensional structure.

Despite these benefits, the synthetic difficulties are substantial. As Buchanan et al. note, "the cyclization process is inherently thermodynamically disfavored due to the loss of rotational entropy and the energy barrier associated with amide bond formation." To achieve efficient cyclization, researchers must operate under kinetic control, typically employing dilute concentrations (1 to 5 mM), low or ambient temperatures, and highly activated reaction partners.

The review distills the major synthetic bottlenecks into three core challenges:

• Sequence dependence: Cyclization efficiency varies greatly with amino acid composition. No universal conditions apply across different molecular targets, so each cyclic peptide often requires individualized optimization of reaction parameters.
• Epimerization risk: Epimerization, particularly during the cyclization step, persists as a constant threat. Careful selection of coupling reagents and reaction conditions is required to preserve stereochemical integrity.
• Structural complexity: Many cyclic peptides incorporate non-natural amino acids, N-methylated residues, ester linkages, and other non-canonical structural elements. These features significantly complicate synthetic route design and final purification.

Emerging Strategies in Cyclic Peptide Synthesis

Through systematic classification and comparison of dozens of total synthesis studies on natural cyclic peptides published since 2017, Buchanan et al. identified several clear research trends.

Refinement of head-to-tail cyclization approaches. Head-to-tail cyclization remains the most widely used strategy, but its conditions are evolving. Traditional methods rely on extremely dilute reactions. Recent studies increasingly employ conformational preorganization by incorporating dehydroamino acids, proline residues, or pseudoproline units. These modifications promote favorable conformations, enabling cyclization at higher concentrations and improving yield and scalability.

Growing adoption of side-chain cyclization strategies. Side-chain-to-side-chain linkages, including disulfide bonds, thioether bonds, and aryl ether bridges, are being used more extensively. These approaches enable the construction of bicyclic and polycyclic structures. They often show higher reaction efficiency due to the closer spatial proximity of reactive groups, reducing reliance on highly dilute conditions.

Integration of synthesis with biological evaluation. Synthetic strategies are increasingly combined with biological activity studies. Many recent works not only confirm structural identity but also evaluate antimicrobial, anticancer, and antiparasitic activities. Structure–activity relationship (SAR) analyses are widely used to identify key functional elements, indicating that cyclic peptide synthesis is now closely integrated into the drug discovery and optimization process.

Classification of Macrocyclization Strategies

The review classifies cyclic peptide synthesis into four fundamental strategies based on the connectivity between reactive termini: head-to-tail, head-to-side-chain, tail-to-side-chain, and side-chain-to-side-chain. These distinct cyclization modes offer different advantages and applications.

The literature presents numerous case studies illustrating the applicability and technical evolution of these strategies. For example, side-chain-to-side-chain approaches enable the synthesis of complex bicyclic natural products that are otherwise difficult to access via linear routes.

Bridging the Gap Between Research and Scalable Synthesis

Despite the innovative strategies showcased in the literature, a significant gap persists between laboratory-scale success and reproducible, scalable industrial processes. Several factors contribute to this disconnect:

• Sequence dependence: Protocols optimized for one specific molecule often fail when applied to a new sequence, limiting the transferability of methodological advances.
• Scalability constraints: Most efficient macrocyclizations still require dilute concentrations below 5 mM, resulting in large solvent volumes, extended processing times, and increased purification burdens.
• Complexity management: Cyclic peptides incorporating non-natural amino acids, N-methylated residues, or non-amide linkages introduce additional challenges with epimerization and side reactions.
• Design-synthesis disconnect: Early-stage designs based on biological activity may overlook synthetic feasibility, protecting group strategies, and scalability considerations.

To address these challenges, specialized synthesis platforms have developed comprehensive technical frameworks that span design, synthesis, and analysis. These frameworks help researchers translate literature strategies into reproducible, scalable, and reliable outcomes. Key elements include:

• Feasibility assessment: Systematic analysis of target sequences using literature case studies to anticipate optimal cyclization strategies, protecting group choices, and potential problem sequences.
• Cyclization optimization: Broad libraries of reaction screening data allow rapid identification of suitable coupling reagents, base systems, concentration ranges, and temperature conditions for each unique sequence.
• Complex structure support: Platforms that handle N-methylated amino acids, non-natural residues, D-amino acids, and ester or other non-amide linkages, employing low-racemization coupling reagents when needed.
• Stereochemical integrity: For sequences with high epimerization risk, carefully controlled conditions preserve the correct configuration throughout the synthesis.

These capabilities are particularly valuable for early-stage research programs where structural parameters are still being defined. Conformational analysis, virtual library construction, binding hypothesis generation, and developability assessment can guide decision-making before synthesis begins, reducing the risk of costly dead ends.

Frequently Asked Questions

Q: Why is head-to-tail cyclization considered thermodynamically disfavored, and how do researchers overcome this?

A: The cyclization reaction requires the linear peptide to adopt a conformation where the N-terminal amine and C-terminal carboxylic acid are close in space. This restriction costs rotational entropy, making the process energetically unfavorable. Researchers overcome this by operating under kinetic control with highly activated coupling reagents, using dilute solutions (1 to 5 mM) to minimize intermolecular side reactions, and increasingly by incorporating conformational preorganization elements such as proline residues or pseudoproline units that bias the molecule toward a cyclization-friendly conformation.

Q: What is meant by "sequence dependence" in cyclic peptide synthesis, and why is it problematic?

A: Sequence dependence means that the efficiency of cyclization varies dramatically with the specific amino acid composition and order of the peptide. Steric hindrance, side-chain interactions, and backbone conformation all influence whether cyclization will proceed cleanly. This is problematic because no single set of reaction conditions works for all targets. Each new cyclic peptide often requires individual optimization of coupling reagents, concentration, temperature, and solvent, which slows down the drug discovery process.

Q: Which macrocyclization strategy is most commonly used, and when would researchers choose a side-chain approach instead?

A: Head-to-tail cyclization is the most widely used strategy for producing all-amide cyclic peptides. However, researchers may choose side-chain-to-side-chain approaches when they need to construct bicyclic or polycyclic structures, lock a specific conformation, or improve metabolic stability. Side-chain linkages such as disulfide or thioether bonds often proceed with higher efficiency because the reactive groups are spatially closer, reducing the need for highly dilute conditions.

Q: How does conformational preorganization improve cyclic peptide synthesis?

A: Conformational preorganization involves introducing structural elements (such as proline, dehydroamino acids, or pseudoproline units) that bias the linear peptide toward a favorable cyclic conformation. This reduces the entropic penalty of cyclization, allowing the reaction to proceed at higher concentrations (above 5 mM) with improved yield and scalability. It also minimizes competing side reactions like dimerization or oligomerization, making the process more reproducible for industrial applications.

Reference: Buchanan, D., et al. "Natural cyclic peptides: Synthetic strategies and biomedical applications." Biomedicines 13, no. 1 (2025): 240. Image adapted from Figure 1 of same publication, used under CC BY 4.0.